First Air Canada Rouge 737 MAX aircraft featuring personal seatback entertainment, Fast, Free Wi-Fi and reclining seats, is now in service Air Canada Rouge’s new Vancouver crew base opens today, growing leisure travel options from Western Canada 45 Boeing 737 MAX are expected to transition to Rouge by the end of 2026, supporting Air Canada cabin upgrades across North AmericaMONTRÉAL, March 05, 2026 (GLOBE NEWSWIRE) — Air Canada today announced the first of its updated Boeing 737 MAX 8 aircraft has entered service at Air Canada Rouge, introducing the industry’s best leisure carrier experience. This marks the latest milestone in Rouge’s comprehensive cabin renewal program, focused on delivering a more comfortable, connected, and consistent onboard experience.This fleet transition will allow most customers flying Rouge leisure...

Reverse Split Intended to Increase Per-Share Trading Price; May Support a Potential Exchange Uplisting Following the Reverse Stock Split, the Company’s ticker symbol on the OTCQB is expected to trade under the symbol DUKRD for 20 trading days Fort Lauderdale, FL, March 05, 2026 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics and drone-based solutions for civilian and defense markets, today announced that a reverse stock split of the Company’s issued and outstanding common shares, par value $0.0001 per share (the “Common Stock”) at a ratio of 25-for-1 (the “Reverse Stock Split”) is expected to be implemented at market open on March 6, 2026. The Company’s Common Stock will begin trading on the OTCQB on a post-split basis at the market open...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. KELLOGG, Idaho and VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR | OTCQB: BHLL), is pleased to announce that it has closed its previously announced “best efforts” private placement offering of units (the “LIFE Units”) of the Company. The Company issued 150,808,332 LIFE Units (approximately 4,308,809 LIFE Units on a post-consolidated basis1) at a price of C$0.18 per LIFE Unit (C$6.30 on a post-consolidated basis1) for gross proceeds of C$27,145,500 (the “Brokered Offering”), which included the full exercise of the agents’ overallotment option. The Company also issued 8,926,668 additional LIFE Units (approximately 255,048 LIFE Units on a post-consolidated...

Three Sites Now Live as Blink Advances EV Charging Rollout of 220 Planned Charging Ports Across 90 Korian Locations Throughout Belgium Antwerp, BELGIUM, March 05, 2026 (GLOBE NEWSWIRE) — Korian Belgium, a provider of elderly care services, has selected Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator and provider of electric vehicle (EV) charging equipment and services, as its EV charging collaborator for a nationwide EV charging project. For this collaboration, Blink plans to invest in and deploy over 200 Blink-owned chargers across 90 Korian locations throughout Belgium, creating one the largest EV charging networks in the Belgian elderly care sector. A similar roll-out for Korian Netherlands is planned. By choosing Blink’s fully financed investment model, Korian enables the rapid...

Company Continues Expansion into North America and Europe as Part of Global Medical Aesthetics Strategy HONG KONG, March 05, 2026 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”), a technology-driven multinational enterprise focused on healthcare services, medical aesthetics, and advanced biotechnology applications, today provided its 2026–2027 business outlook and strategic growth priorities as the Company continues executing its expansion into global healthcare and medical aesthetics markets. Over the past year, Visionary has progressively repositioned its strategic focus toward higher-margin healthcare services and medical aesthetics businesses. The Company has previously announced initiatives aimed at expanding into international healthcare markets, including North America and Europe, through...

Yantai, China, March 05, 2026 (GLOBE NEWSWIRE) — Decent Holding Inc. (Nasdaq: DXST) (“Decent” or the “Company”), an established wastewater treatment services provider in China, today announced its strategic entry into the senior health and wellness sector. The Company has officially launched an artificial intelligence-driven digital health and community-based senior care platform through its subsidiary, Suncare (Shanghai) Health Technology Co., Ltd. (“Suncare”).  Suncare is positioned to serve as the Company’s primary operational hub for senior health and wellness in the Asia-Pacific region. The platform is designed to build a comprehensive service network that integrates artificial intelligence with community-based care to serve aging populations across the senior care continuum. An Integrated Ecosystem for Senior...

Compare Internet AwardThe recognition reflects Kinetic’s commitment to delivering a better internet experience.BROKEN ARROW, Okla., March 05, 2026 (GLOBE NEWSWIRE) — Kinetic, a leader in residential and business fiber internet, proudly announced today that it won the 2026 Best Multi-Gig Internet Value Award from Compare Internet. The recognition reflects Kinetic’s commitment to delivering a better internet experience, for better value, to more communities across the country. The third-party expert technology comparison website recognized Kinetic for its multi-gig speed plans packed with features like Wifi 7, as well as its long-term price stability to eliminate bill creep. Kinetic’s 3-year price guarantee differs from other providers that hook customers with a great promotional rate for year one then increases each year...

COPENHAGEN, Denmark, March 5, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and announces full year 2025 financial results. Business highlights2025 was a transformational year for Evaxion with significant strengthening of our fundamental business both strategically, scientifically and financially through achievement of several milestones. Highlights include:The historic licensing of our infectious disease vaccine candidate EVX-B3 by MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) Unprecedented two-year phase 2 data for our personalized cancer vaccine candidate EVX-01 demonstrating impressive clinical outcomes Replenishing of our R&D pipeline adding EVX-04, an off-the-shelf vaccine...

SAHUARITA, Ariz., March 05, 2026 (GLOBE NEWSWIRE) — Torreon Group, Inc. (OTCID: NXTN) today announced that ABOA Development has commenced full-scale production construction at its Santa Rita Villas townhome development in Sahuarita, Arizona, marking a critical transition from prototype validation to volume manufacturing of residential units across 46 build-ready lots. Following the successful $1.65 million sale of five prototype townhomes under a master contract for 51 total units, the company has mobilized engineering, excavation, and construction resources to begin the first production phase of 24 townhomes on Pendlebury Avenue, representing approximately $7.6 million in projected gross revenue. “The prototype phase proved market demand and validated our construction efficiency. Now we’re executing at scale,”...

BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christopher Hite, an accomplished executive with decades of corporate and financial strategy leadership experience in the biopharmaceutical sector, to Vera Therapeutics’ Board of Directors. “It is a pleasure to welcome Chris to our Board of Directors at this exciting juncture in Vera Therapeutics’ trajectory as we near the potential launch of our first-in-class dual BAFF/APRIL inhibitor for patients with IgA nephropathy,” said Marshall Fordyce, M.D., Founder and Chief Executive Officer of Vera Therapeutics. “Chris brings deep leadership and strategic expertise...